Potential Of Mahkota Dewa Fruit (Phaleria macrocarpa) Flavonoids Extract and Dienogest to Reduce IL-17A Levels in Mice Endometriosis Model

Authors

  • Ana Paramita Prastiwi Master Program of Midwifery, Faculty of Medicine, Brawijaya University, Malang, East Java Indonesia
  • Leni Ria Ariana Master Program of Midwifery, Faculty of Medicine, Brawijaya University, Malang, East Java Indonesia
  • Gema Alya Salsabila Master Program of Midwifery, Faculty of Medicine, Brawijaya University, Malang, East Java Indonesia
  • Sutrisno Sutrisno Division of Fertility, Endocrinology, and Reproduction, Department of Obstetrics and Gynecology, Saiful Anwar General Hospital, University of Brawijaya, Malang, East Java Indonesia
  • Nurdiana Nurdiana Laboratory of Pharmacology, Faculty of Medicine, Brawijaya University, Malang, East Java, Indonesia
  • Nanik Setijowati Public Health Department, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
  • I Wayan Agung Indrawan Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Brawijaya, East Java, Indonesia

DOI:

https://doi.org/10.31964/mltj.v9i2.536

Keywords:

Dienogest, flavonoid, interleukin 17A, Phaleria macrocarpa

Abstract

Endometriosis is an inflammatory disease that occurs in glands outside the endometrium. Interleukin 17 (IL-17) is a proinflammatory cytokine degrading Th17 cells, which play an essential role in several inflammatory diseases. IL-17 expression is upregulated in serum, peritoneal fluid (PF), and endometriotic lesions from patients with endometriosis. Usually, treatment for endometriosis is dienogest. However, it has many side effects if used long-term. Fruit and seeds of Phaleria macrocarpa have various critical biological activities in the form of extracts such as antimicrobial, anti-inflammatory, and antioxidant activities. This study aims to analyze the effect of comparing flavonoid fruit extract of Phaleria macrocarpa and dienogest on IL-17A levels in endometriosis mice. A total of 35 endometriosis model mice were divided into seven groups, namely the group of healthy mice (without any treatment), the endometriosis group, and the endometriosis group, which were given the treatment of flavonoid fruit extracts of Phaleria macrocarpa and dienogest. The sample used in this study was peritoneal fluid. The enzyme-linked immunosorbent assay (ELISA) measured IL-17A levels in each observation group. The hypothesis was tested using One-Way ANOVA analysis with SPSS software version 26. This study found a significant difference (p<0.05) between the mean values of the positive control group and the negative control group. There was also a significant difference (p<0.05) in the mean value IL-17 between the treatment groups that were given sphalerite macrocarpa and dienogest extracts. Flavonoid fruit extract of Phaleria macrocarpa had a significant effect on reducing IL-17A levels in endometriosis model mice, and there is a significant difference with dienogest. Thus, the flavonoid fruit extract of Phaleria macrocarpa can potentially treat endometriosis by decreasing inflammatory factors.

References

Al-Khayri, J. M., Sahana, G. R., Nagella, P., Joseph, B. V., Alessa, F. M., & Al-Mssallem, M. Q. (2022). Flavonoids as Potential Anti-Inflammatory Molecules: A Review. Molecules, 27(9). https://doi.org/10.3390/molecules27092901

Alara, O., & Olalere, O. (2016). Review on Phaleria macrocarpa Pharmacological and Phytochemical Properties. Drug Designing, 5. https://doi.org/10.4172/2169-0138.1000134

Altaf, R., Asmawi, M. Z. Bin, Dewa, A., Sadikun, A., & Umar, M. I. (2013). Phytochemistry and medicinal properties of Phaleria macrocarpa (Scheff.) Boerl. extracts. Pharmacognosy Reviews, 7(13), 73–80. https://doi.org/10.4103/0973-7847.112853

Andres, M. de P., Lopes, L. A., Baracat, E. C., & Podgaec, S. (2015). Dienogest in the treatment of endometriosis: systematic review. Archives of Gynecology and Obstetrics, 292(3), 523–529. https://doi.org/10.1007/s00404-015-3681-6

Bedaiwy, M. A., Allaire, C., & Alfaraj, S. (2017). Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy. Fertility and Sterility, 107(3), 537–548. https://doi.org/https://doi.org/10.1016/j.fertnstert.2016.12.024

Calabrese, V., Cornelius, C., Trovato-Salinaro, A., Cambria, M., Locascio, M., Rienzo, L., Condorelli, D., Mancuso, C., De Lorenzo, A., & Calabrese, E. (2010). The Hormetic Role of Dietary Antioxidants in Free Radical-Related Diseases. Current Pharmaceutical Design, 16(7), 877–883. https://doi.org/10.2174/138161210790883615

Dietrich, H., Knobel, C., Portmann, L., Metzler, J., Muendane, A., Niggli, A., Neumeier, M. S., Imesch, P., & Merki-Feld, G. S. (2023). Endometriosis features and dienogest tolerability in women with depression: a case-control study. European Journal of Contraception and Reproductive Health Care, 28(3), 198–204. https://doi.org/10.1080/13625187.2023.2199899

Ghiasi, M., Kulkarni, M. T., & Missmer, S. A. (2020). Is Endometriosis More Common and More Severe Than It Was 30 Years Ago? Journal of Minimally Invasive Gynecology, 27(2), 452–461. https://doi.org/10.1016/j.jmig.2019.11.018

Grandi, G., Mueller, M., Bersinger, N. A., Cagnacci, A., Volpe, A., & McKinnon, B. (2016). Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. Inflammation Research, 65(3), 183–192. https://doi.org/10.1007/s00011-015-0909-7

Hayashi, A., Tanabe, A., Kawabe, S., Hayashi, M., Yuguchi, H., Yamashita, Y., Okuda, K., & Ohmichi, M. (2012). Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis. Journal of Ovarian Research, 5(1), 1. https://doi.org/10.1186/1757-2215-5-31

Leyva-López, N., Gutierrez-Grijalva, E. P., Ambriz-Perez, D. L., & Basilio Heredia, J. (2016). Flavonoids as cytokine modulators: A possible therapy for inflammation-related diseases. International Journal of Molecular Sciences, 17(6). https://doi.org/10.3390/ijms17060921

Liu, W., Feng, Y., Yu, S., Fan, Z., Li, X., Li, J., & Yin, H. (2021). The Flavonoid Biosynthesis Network in Plants. International Journal of Molecular Sciences, 22(23). https://doi.org/10.3390/ijms222312824

Maharani, M., Lajuna, L., Yuniwati, C., Sabrida, O., & Sutrisno, S. (2021). Phytochemical characteristics from Phaleria macrocarpa and its inhibitory activity on the peritoneal damage of endometriosis. Journal of Ayurveda and Integrative Medicine. https://doi.org/10.1016/j.jaim.2020.06.002

Maleki, S. J., Crespo, J. F., & Cabanillas, B. (2019). Anti-inflammatory effects of flavonoids. Food Chemistry, 299(March). https://doi.org/10.1016/j.foodchem.2019.125124

Matteo, M., Cicinelli, E., Neri, M., Carrubba, R., Carpagnano, F. A., Romeo, F., Scutiero, G., Greco, P., Garlanda, C., Vendemiale, G., Levi Setti, P. E., & Serviddio, G. (2017). Pro-inflammatory M1/Th1 type immune network and increased expression of TSG-6 in the eutopic endometrium from women with endometriosis. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 218, 99–105. https://doi.org/10.1016/j.ejogrb.2017.08.014

Mehdizadeh Kashi, A., Niakan, G., Ebrahimpour, M., Allahqoli, L., Hassanlouei, B., Gitas, G., & Alkatout, I. (2022). A randomized, double-blind, placebo-controlled pilot study of the comparative effects of dienogest and the combined oral contraceptive pill in women with endometriosis. International Journal of Gynecology and Obstetrics. https://doi.org/10.1002/ijgo.13677

Mendes, L. F., Gaspar, V. M., Conde, T. A., Mano, J. F., & Duarte, I. F. (2019). Flavonoid-mediated immunomodulation of human macrophages involves key metabolites and metabolic pathways. Scientific Reports, 9(1), 1–10. https://doi.org/10.1038/s41598-019-51113-z

Ribeiro, D., Freitas, M., Lima, J. L. F. C., & Fernandes, E. (2015). Proinflammatory Pathways: The Modulation by Flavonoids. Medicinal Research Reviews, 35(5), 877–936. https://doi.org/10.1002/med.21347

Shi, J.-L., Zheng, Z.-M., Chen, M., Shen, H.-H., Li, M.-Q., & Shao, J. (2022). IL-17: an important pathogenic factor in endometriosis. International Journal of Medical Sciences, 19(4), 769–778. https://doi.org/10.7150/ijms.71972

Sutrisno, S., Sulistyorini, C., Manungkalit, E. M., Winarsih, L., Noorhamdani, N., & Winarsih, S. (2017). The effect of genistein on TGF-β signal, dysregulation of apoptosis, cyclooxygenase-2 pathway, and NF-kB pathway in mice peritoneum of endometriosis model. Middle East Fertility Society Journal, 22(4), 295–299. https://doi.org/https://doi.org/10.1016/j.mefs.2017.05.002

Yoshino, O., Yamada-Nomoto, K., Kano, K., Ono, Y., Kobayashi, M., Ito, M., Yoneda, S., Nakashima, A., Shima, T., Onda, T., Osuga, Y., Aoki, J., & Saito, S. (2019). Sphingosine 1 Phosphate (S1P) Increased IL-6 Expression and Cell Growth in Endometriotic Cells. Reproductive Sciences, 26(11), 1460–1467. https://doi.org/10.1177/1933719119828112

Yuan, M., Li, D., An, M., Li, Q., Zhang, L., & Wang, G. (2017). Rediscovering peritoneal macrophages in a murine endometriosis model. Human Reproduction, 32(1), 94–102. https://doi.org/10.1093/humrep/dew274

Zhou, J., Chern, B. S., Barton-Smith, P., Phoon, J. W., Tan, T. Y., Viardot-Foucault, V., Ku, C. W., Tan, H. H., Chan, J. K., & Lee, Y. H. (2020). Peritoneal Fluid Cytokines Reveal New Insights of Endometriosis Subphenotypes. In International Journal of Molecular Sciences, 21(10). https://doi.org/10.3390/ijms21103515

Downloads

Published

2023-12-23

How to Cite

Prastiwi, A. P., Ariana, L. R., Salsabila, G. A., Sutrisno, S., Nurdiana, N., Setijowati, N., & Indrawan, I. W. A. . (2023). Potential Of Mahkota Dewa Fruit (Phaleria macrocarpa) Flavonoids Extract and Dienogest to Reduce IL-17A Levels in Mice Endometriosis Model. Medical Laboratory Technology Journal, 9(2). https://doi.org/10.31964/mltj.v9i2.536

Issue

Vol. 9 No. 2 (2023): December

Section

Articles

License

Copyright (c) 2023 Ana Paramita Prastiwi, Leni Ria Ariana, Gema Alya Salsabila, Sutrisno Sutrisno, Nurdiana Nurdiana, Nanik Setijowati, I Wayan Agung Indrawan

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Publishing your paper with Medical Laboratory Technology Journal (MLTJ) means that the author or authors retain the copyright in the paper. MLTJ granted an author(s) rights to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by MLTJ in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage.

MLTJ journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially. MLTJ journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:


BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
SA: If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

Most read articles by the same author(s)